[Federal Register Volume 87, Number 190 (Monday, October 3, 2022)]
[Notices]
[Page 59805]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-21396]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Advisory Council on Alzheimer's Research, Care, and Services;
Meeting
AGENCY: Assistant Secretary for Planning and Evaluation, HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: This notice announces the public meeting of the Advisory
Council on Alzheimer's Research, Care, and Services (Advisory Council).
The Advisory Council provides advice on how to prevent or reduce the
burden of Alzheimer's disease and related dementias (ADRD) on people
with the disease and their caregivers. During the October 24, 2022
meeting the Advisory Council will hear presentations on access to long-
term services and supports as well as end-of-life challenges for people
living with ADRD. Federal agencies will provide updates including a
presentation from the Administration for Community Living on the new
National Strategy to Support Family Caregivers.
DATES: The meeting will be held on October 24, 2022 from 9:00 a.m. to
4:30 p.m. EST.
ADDRESSES: The meeting will be a hybrid of in-person and virtual. The
meeting will be held in Room 800 of the Hubert H. Humphrey Building,
200 Independence Avenue SW, Washington, DC 20201. It will also stream
live at www.hhs.gov/live.
Comments: Time is allocated on the agenda to hear public comments
from 4:00 p.m. to 4:30 p.m. The time for oral comments will be limited
to two (2) minutes per individual. In order to provide a public
comment, please register by emailing your name to [email protected] by
Thursday, October 20. Registered commenters may provide their comments
either in-person or virtually on Friday, October 21. Registered
commenters attending virtually will receive both a dial-in number and a
link to join the meeting virtually; individuals will have the choice to
either join virtually via the link, or to call in only by using the
dial-in number. Note: There may be a 30-45 second delay in the
livestream video presentation of the conference. For this reason, if
you have pre-registered to submit a public comment, it is important to
connect to the meeting by 3:45 p.m. to ensure that you do not miss your
name and allotted time when called. If you miss your name and allotted
time to speak, you may not be able to make your public comment. All
participant audio lines will be muted for the duration of the meeting
and only unmuted by the Host at the time of the participant's public
comment. Should you have questions during the session email
[email protected] and someone will respond to your message as quickly as
possible.
In order to ensure accuracy, please submit a written copy of oral
comments for the record by emailing [email protected] by Tuesday, October
25. These comments will be shared on the website and reflected in the
meeting minutes.
In lieu of oral comments, formal written comments may be submitted
for the record by Tuesday, October 25 to Helen Lamont, Ph.D., OASPE,
200 Independence Avenue SW, Room 424E, Washington, DC 20201. Comments
may also be sent to [email protected]. Those submitting written comments
should identify themselves and any relevant organizational
affiliations.
FOR FURTHER INFORMATION CONTACT: Helen Lamont, 202-260-6075,
[email protected]. Note: The meeting will be available to the public
live at www.hhs.gov/live
SUPPLEMENTARY INFORMATION: Notice of these meetings is given under the
Federal Advisory Committee Act (5 U.S.C. app. 2, section 10(a)(1) and
(a)(2)). Topics of the Meeting: Aducanumab, dementia risk reduction,
recommendations.
Procedure and Agenda: The meeting will be webcast at www.hhs.gov/live and video recordings will be added to the National Alzheimer's
Project Act website when available, after the meeting.
Authority: 42 U.S.C. 11225; Section 2(e)(3) of the National
Alzheimer's Project Act. The panel is governed by provisions of Public
Law 92-463, as amended (5 U.S.C. appendix 2), which sets forth
standards for the formation and use of advisory committees.
Dated: September 28, 2022.
Benjamin Sommers,
Senior Official Performing the Duties of the Assistant Secretary for
Planning and Evaluation, Deputy Assistant Secretary for Health Policy.
[FR Doc. 2022-21396 Filed 9-30-22; 8:45 am]
BILLING CODE 4150-05-P